top of page

1 Sample, up to 100 Cycles

Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png

We automate cytometry workflows for T-cell analysis to accelerate immune therapies R&D.

​

We allow to track T cells with multiple antigenic specificities within the same sample.

Screenshot 2024-08-19 at 11.04.59 PM.png

For demonstration purposes only; actual product may vary.

Meet 100XBIO Cycler: A new way to automate cytometry experiments.

Screenshot_2024-08-01_at_3.29_edited.png

Let's talk

"I'm doing it, because I love T-cell immunology."

Get in Touch

100XBIO @C2I Accelerator

299 Washington St

Woburn, MA 01801 

  • LinkedIn
  • X
  • YouTube
bottom of page